Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ozlem Türeci

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2013
Antigen identification using SEREXUgur Sahin, Ozlem Türeci
Human Molecular Genetics|July 1, 2006
The human X chromosome is enriched for germline genes expressed in premeiotic germ cells of both sexesMichael Koslowski, Ugur Sahin, Christoph Huber, et al.
Methods in Molecular Medicine|December 9, 2004
Identification of tumor-associated autoantigens with SEREXOzlem Türeci, Dirk Usener, Sandra Schneider, et al.
Molecular Cancer|September 29, 2009
Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2Michael Koslowski, Ozlem Türeci, Christoph Huber, et al.
Oncoimmunology|August 31, 2012
Targeting the tumor mutanome for personalized vaccination therapySebastian Kreiter, John C Castle, Ozlem Türeci, et al.
Autoimmunity Reviews|October 11, 2003
Autoimmunity seen through the SEREX-scopePhilippe Krebs, Michael Kurrer, Ugur Sahin, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Antitumor vaccination with synthetic mRNA: strategies for in vitro and in vivo preclinical studiesMustafa Diken, Sebastian Kreiter, Abderraouf Selmi, et al.
Cancer Research|May 3, 2008
MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processesMichael Koslowski, Ugur Sahin, Karl Dhaene, et al.
Journal of Immunological Methods|December 9, 2003
SeroGRID: an improved method for the rapid selection of antigens with disease related immunogenicityPatricia Krause, Ozlem Türeci, Patrick Micke, et al.
BMC Cancer|December 6, 2013
NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cellsMeike Wagner, Michael Koslowski, Claudia Paret, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2013
Antigen identification using SEREXUgur Sahin, Ozlem Türeci
Human Molecular Genetics|July 1, 2006
The human X chromosome is enriched for germline genes expressed in premeiotic germ cells of both sexesMichael Koslowski, Ugur Sahin, Christoph Huber, et al.
Methods in Molecular Medicine|December 9, 2004
Identification of tumor-associated autoantigens with SEREXOzlem Türeci, Dirk Usener, Sandra Schneider, et al.
Molecular Cancer|September 29, 2009
Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2Michael Koslowski, Ozlem Türeci, Christoph Huber, et al.
Oncoimmunology|August 31, 2012
Targeting the tumor mutanome for personalized vaccination therapySebastian Kreiter, John C Castle, Ozlem Türeci, et al.
Autoimmunity Reviews|October 11, 2003
Autoimmunity seen through the SEREX-scopePhilippe Krebs, Michael Kurrer, Ugur Sahin, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Antitumor vaccination with synthetic mRNA: strategies for in vitro and in vivo preclinical studiesMustafa Diken, Sebastian Kreiter, Abderraouf Selmi, et al.
Cancer Research|May 3, 2008
MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processesMichael Koslowski, Ugur Sahin, Karl Dhaene, et al.
Journal of Immunological Methods|December 9, 2003
SeroGRID: an improved method for the rapid selection of antigens with disease related immunogenicityPatricia Krause, Ozlem Türeci, Patrick Micke, et al.
BMC Cancer|December 6, 2013
NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cellsMeike Wagner, Michael Koslowski, Claudia Paret, et al.
Pageof 4